Medical Developments (Australia) Market Value
| MVP Stock | 0.68 0.08 10.53% |
| Symbol | Medical |
Medical Developments 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medical Developments' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medical Developments.
| 01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in Medical Developments on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding Medical Developments International or generate 0.0% return on investment in Medical Developments over 30 days. Medical Developments is related to or competes with Home Consortium, Ambertech, EROAD, WiseTech Global, Thorney Technologies, and Australian Unity. Medical Developments is entity of Australia More
Medical Developments Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medical Developments' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medical Developments International upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.25 | |||
| Information Ratio | 0.1181 | |||
| Maximum Drawdown | 63.08 | |||
| Value At Risk | (7.50) | |||
| Potential Upside | 11.54 |
Medical Developments Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medical Developments' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medical Developments' standard deviation. In reality, there are many statistical measures that can use Medical Developments historical prices to predict the future Medical Developments' volatility.| Risk Adjusted Performance | 0.0963 | |||
| Jensen Alpha | 0.9647 | |||
| Total Risk Alpha | 1.04 | |||
| Sortino Ratio | 0.1849 | |||
| Treynor Ratio | (22.18) |
Medical Developments Backtested Returns
Medical Developments is out of control given 3 months investment horizon. Medical Developments has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.11% are justified by taking the suggested risk. Use Medical Developments Risk Adjusted Performance of 0.0963, downside deviation of 5.25, and Mean Deviation of 4.24 to evaluate company specific risk that cannot be diversified away. Medical Developments holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.0435, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medical Developments are expected to decrease at a much lower rate. During the bear market, Medical Developments is likely to outperform the market. Use Medical Developments coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to analyze future returns on Medical Developments.
Auto-correlation | -0.66 |
Very good reverse predictability
Medical Developments International has very good reverse predictability. Overlapping area represents the amount of predictability between Medical Developments time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medical Developments price movement. The serial correlation of -0.66 indicates that around 66.0% of current Medical Developments price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.66 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Medical Developments lagged returns against current returns
Autocorrelation, which is Medical Developments stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medical Developments' stock expected returns. We can calculate the autocorrelation of Medical Developments returns to help us make a trade decision. For example, suppose you find that Medical Developments has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medical Developments regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medical Developments stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medical Developments stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medical Developments stock over time.
Current vs Lagged Prices |
| Timeline |
Medical Developments Lagged Returns
When evaluating Medical Developments' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medical Developments stock have on its future price. Medical Developments autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medical Developments autocorrelation shows the relationship between Medical Developments stock current value and its past values and can show if there is a momentum factor associated with investing in Medical Developments International.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.